| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.21B | +5.7% |
| Cost of Revenue | $1.42B | +8.8% |
| Gross Profit | $784.7M | +2.0% |
| R&D Expense | $195.7M | -3.1% |
| SG&A Expense | $399.7M | +9.4% |
| Operating Income | -$94.9M | -162.2% |
| Pre-tax Income | -$248.1M | -891.1% |
| Income Tax | $6.7M | -40.5% |
| Net Income | -$270.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.0M | -89.5% |
| Accounts Receivable | $741.8M | +12.0% |
| Inventory | $530.7M | +8.4% |
| Current Assets | $1.41B | -7.1% |
| Total Assets | $3.80B | -3.6% |
| Current Liabilities | $752.8M | +11.2% |
| Long-term Debt | $2.62B | -3.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $65.1M | -73.1% |
| Capital Expenditures | $46.4M | -2.8% |
| Investing Cash Flow | -$174.3M | +10.2% |
| Financing Cash Flow | -$106.6M | +22.8% |
| Free Cash Flow | $18.7M | -90.4% |
| -2155.6% |
| EPS (Basic) | -$0.86 | -1328.6% |
| EPS (Diluted) | -$0.86 | -1328.6% |
| Stockholders' Equity |
| $298.4M |
| -17.2% |